ABCB1 p.Gly341Val

Predicted by SNAP2: A: N (53%), C: D (75%), D: D (85%), E: D (91%), F: D (80%), H: D (85%), I: D (85%), K: D (91%), L: D (85%), M: D (85%), N: D (80%), P: D (91%), Q: D (85%), R: D (91%), S: N (53%), T: D (80%), V: D (80%), W: D (91%), Y: D (91%),
Predicted by PROVEAN: A: D, C: D, D: D, E: D, F: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, S: D, T: D, V: D, W: D, Y: D,

[switch to compact view]
Comments [show]
Publications
[hide] Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM
Biochemical, cellular, and pharmacological aspects of the multidrug transporter.
Annu Rev Pharmacol Toxicol. 1999;39:361-98., [PMID:10331089]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Breier A, Barancik M, Sulova Z, Uhrik B
P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Curr Cancer Drug Targets. 2005 Sep;5(6):457-68., [PMID:16178819]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA, Pastan I
Genetic analysis of the multidrug transporter.
Annu Rev Genet. 1995;29:607-49., [PMID:8825488]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Hrycyna CA
Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance.
Semin Cell Dev Biol. 2001 Jun;12(3):247-56., [PMID:11428917]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Ueda K, Taguchi Y, Morishima M
How does P-glycoprotein recognize its substrates?
Semin Cancer Biol. 1997 Jun;8(3):151-9., [PMID:9441945]

Abstract [show]
Comments [show]
Sentences [show]